We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.06B
Turnover
46.34%
1-Year Est. Return
215.32%
This Fund
S&P 500
This Quarter
Est. Return
-12.44%
1 Year Est. Return
+215.32%
3 Year Est. Return
+310.3%
5 Year Est. Return
+497.45%
10 Year Est. Return
+14,692.23%
AUM
$3.27B
AUM Growth
-$685M
(-17%)
Cap. Flow
+$21.7M
Cap. Flow
% of AUM
0.66%
Top 10 Holdings %
Top 10 Hldgs %
61.39%
Holding
65
New
6
Increased
5
Reduced
5
Closed
10
Avg Time Held Equity + Options
1.8
years
Top 10 Avg Time Held Equity + Options
1.6
years
Top 20 Avg Time Held Equity + Options
1.9
years
Avg Time Held Equity only
1.8
years
Top 10 Avg Time Held Equity only
1.6
years
Top 20 Avg Time Held Equity only
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morphic Holding, Inc. Common Stock
MORF
|
+$77M |
| 2 |
Janux Therapeutics
JANX
|
+$69M |
| 3 |
CARGO Therapeutics
CRGX
|
+$27.9M |
| 4 |
Bicycle Therapeutics
BCYC
|
+$20.6M |
| 5 |
iTeos Therapeutics
ITOS
|
+$17.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Pharmaceuticals
ACAD
|
+$75M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$65.8M |
| 3 |
Alector
ALEC
|
+$24.4M |
| 4 |
Nkarta
NKTX
|
+$21.6M |
| 5 |
Ovid Therapeutics
OVID
|
+$18.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.88% |
| 2 | Miscellaneous | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Kyverna Therapeutics
KYTX
$351M
| $3.38M | 0.1% |
450,000
| – | – |
2024 Q1
1 quarter
|
|
52
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| $2.81M | 0.09% |
963,333
| – | – |
2021 Q1
13 quarters
|
|
53
Aligos Therapeutics
ALGS
$30.3M
| $2.24M | 0.07% |
255,579
| – | – |
2021 Q4
10 quarters
|
|
54
DELISTED
Surrozen Inc Warrant
SRZNW
| $730K | 0.02% |
66,665
| – | – |
2021 Q2
12 quarters
|
|
55
DELISTED
CareMax, Inc. Warrant
CMAXW
| $279K | 0.01% |
100,000
| – | – |
2020 Q4
14 quarters
|
|
|
56
Alector
ALEC
$205M
| – | – |
-4,056,548
| Closed | -$24.4M | – |
|
57
Arcutis Biotherapeutics
ARQT
$3.62B
| – | – |
-500,000
| Closed | -$4.96M | – |
|
58
Gossamer Bio
GOSS
$53.6M
| – | – |
-114,943
| Closed | -$10.9M | – |
|
59
CALL
Kodiak Sciences
KOD
$5.39B
| – | – |
-51,100
| Closed | -$269K | – |
|
|
60
Kodiak Sciences
KOD
$5.39B
| – | – |
-1,613,600
| Closed | -$8.49M | – |
|
61
CALL
Kura Oncology
KURA
$808M
| – | – |
-700,000
| Closed | -$14.9M | – |
|
|
62
Nkarta
NKTX
$129M
| – | – |
-2,000,000
| Closed | -$21.6M | – |
|
|
63
Ovid Therapeutics
OVID
$420M
| – | – |
-6,117,400
| Closed | -$18.7M | – |
|
64
PMV Pharmaceuticals
PMVP
$64.7M
| – | – |
-566,879
| Closed | -$964K | – |
|
65
DELISTED
Alpine Immune Sciences Inc
ALPN
| – | – |
-1,000
| Closed | -$39.6K | – |
|
Similar funds
RHJA
ST
ABTD
CFA
DWT
RMC
SIC
FWTB
EcoR1 Capital's Q2 2024 Portfolio in Review
As of Q2 2024, EcoR1 Capital held 65 positions worth $3.27B, down 17% from $3.95B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
EcoR1 Capital's Q2 2024 filing shows 6 new, 5 increased, 5 reduced and 10 closed positions. Its largest new stake was Janux Therapeutics: 1,469,818 shares worth $61.6M. The largest sale was Acadia Pharmaceuticals, an estimated $75M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Miscellaneous.
- EcoR1 Capital's largest Q2 2024 buy was Janux Therapeutics: 1,469,818 shares worth $61.6M.
- EcoR1 Capital added most to Morphic Holding, Inc. Common Stock in Q2 2024, an estimated $77M increase.
- EcoR1 Capital's biggest Q2 2024 reduction was Acadia Pharmaceuticals, cutting an estimated $75M.
- EcoR1 Capital fully exited Alector in Q2 2024, selling an estimated $24.4M.
- EcoR1 Capital's ten largest holdings make up 61% of its $3.27B portfolio in Q2 2024.
- EcoR1 Capital opened 6 new positions and closed 10 in Q2 2024.
- EcoR1 Capital's portfolio value fell 17% quarter-over-quarter to $3.27B.
Based on EcoR1 Capital's 13F filing for Q2 2024, filed 14 Aug 2024.